Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study

Published:2022-08 Issue: Volume:55 Page:152018
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Wang Jinghua,Dai Xiaojuan,Ma Lingying,Wu Sifan,Jin Xuejuan,Ji Zongfei,Chen Huiyong,Ma Lili,Ding Zhenqi,Jiang Lindi,Kong Xiufang

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference29 articles.

1. Diagnosis, management, and outcome of aortitis at a single center;Skeik;Vasc Endovascular Surg,2017

2. One year in review 2018: systemic vasculitis;Elefante;Clin Exp Rheumatol,2018

3. 2021 American College of Rheumatology/vasculitis foundation guideline for the management of giant cell arteritis and takayasu arteritis;Maz;Arthritis Care Res (Hoboken),2021

4. Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study;Ying;Ther Adv Musculoskelet Dis,2020

5. Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis;Wu;Ther Adv Chronic Dis,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-β and SMAD3 signaling pathway activation;Journal of Autoimmunity;2024-09

2. A Glimpse into Humoral Response and Related Therapeutic Approaches of Takayasu’s Arteritis;International Journal of Molecular Sciences;2024-06-13

3. Benefits and challenges of 18F-FDG PET/CT in patients with Takayasu arteritis;Clinical Radiology;2024-06

4. Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study;RMD Open;2024-03

5. Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre;RMD Open;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3